Entries tagged "ConvaTec"
Bristol-Myers Squibb executes a successful divestiture.
Bristol-Myers plans to raise $500M-plus selling shares in Mead Johnson Nutrition Co. Cravath's Ronald Cami and Susan Webster are advising.
As the credit crunch has grown worse, even the best deals are having trouble getting financed.
It's been about a year since the markets froze up. As a result, this year's Private Equity Deals of the Year are a particularly eclectic bunch, featuring winners, losers and everything in between.
Bristol-Myers demanded a degree of deal certainty when it auctioned its ConvaTec unit.
